keyword
https://read.qxmd.com/read/23377551/therapeutic-induction-of-autophagy-to-modulate-neurodegenerative-disease-progression
#21
REVIEW
Warren E Hochfeld, Shirley Lee, David C Rubinsztein
There is accumulating evidence that aggregating, misfolded proteins may have an impact on autophagic function, suggesting that this could be a secondary pathological mechanism in many diseases. In this review, we focus on the role of autophagy in four major neurodegenerative diseases: Alzheimer disease (AD), Huntington's disease (HD), Parkinson's disease (PD) and amyotropic lateral sclerosis.
May 2013: Acta Pharmacologica Sinica
https://read.qxmd.com/read/21545774/concomitant-cns-pathology-in-a-patient-with-amyotropic-lateral-sclerosis-following-poliomyelitis-in-childhood
#22
JOURNAL ARTICLE
M Casula, K Steentjes, E Aronica, B M van Geel, D Troost
Post-polio syndrome (PPS) develops in approximately 30% of polio survivors several decades after the acute attack of paralytic poliomyelitis. Some of these patients develop post-poliomyelitis muscular atrophy (PPMA) which is characterized by a slowly progressive muscle weakness. Due to its clinicopathological features, investigators have often studied PPS and PPMA in association with amyotrophic lateral sclerosis (ALS), the underlying hypothesis being an increased risk of developing ALS from a prior acute paralytic poliomyelitis...
May 2011: Clinical Neuropathology
https://read.qxmd.com/read/21434813/a-morphometric-study-of-the-vagus-nerve-in-amyotropic-lateral-sclerosis-with-circulatory-collapse
#23
COMPARATIVE STUDY
Toshio Shimizu, Michiyuki Hayashi, Akihiro Kawata, Toshio Mizutani, Kazuhiko Watabe, Shiro Matsubara
Amyotrophic lateral sclerosis (ALS) shows peculiar abnormalities of the autonomic nervous system, including sympathetic hyperactivity, which might result in sudden death. In general, the sympathetic hyperactivity could be caused by disruption of vagal inhibition. Our objective was to evaluate the vagus nerve morphometrically in autopsy cases of ALS with sympathetic hyperactivity and circulatory collapse (CC). We investigated 10 autopsied ALS patients, six of whom had exhibited autonomic storms or CC. We also examined 10 patients without ALS as controls, and one patient with Guillain-Barré syndrome (GBS) who died from CC, for comparison...
September 2011: Amyotrophic Lateral Sclerosis
https://read.qxmd.com/read/21140288/trpm2-cation-channels-oxidative-stress-and-neurological-diseases-where-are-we-now
#24
REVIEW
Mustafa Nazıroğlu
The Na+ and Ca(2+)-permeable melastatin related transient receptor potential 2 (TRPM2) channels can be gated either by ADP-ribose (ADPR) in concert with Ca(2+) or by hydrogen peroxide (H(2)O(2)), an experimental model for oxidative stress, binding to the channel's enzymatic Nudix domain. Since the mechanisms that lead to TRPM2 gating in response to ADPR and H(2)O(2) are not understood in neuronal cells, I summarized previous findings and important recent advances in the understanding of Ca(2+) influx via TRPM2 channels in different neuronal cell types and disease processes...
March 2011: Neurochemical Research
https://read.qxmd.com/read/20971133/motor-neuron-trophic-factors-therapeutic-use-in-als
#25
REVIEW
Thomas W Gould, Ronald W Oppenheim
The modest effects of neurotrophic factor (NTF) treatment on lifespan in both animal models and clinical studies of Amyotropic Lateral Sclerosis (ALS) may result from any one or combination of the four following explanations: 1.) NTFs block cell death in some physiological contexts but not in ALS; 2.) NTFs do not rescue motoneurons (MNs) from death in any physiological context; 3.) NTFs block cell death in ALS but to no avail; and 4.) NTFs are physiologically effective but limited by pharmacokinetic constraints...
June 24, 2011: Brain Research Reviews
https://read.qxmd.com/read/20632970/cannabinoid-receptors-and-endocannabinoids-role-in-neuroinflammatory-and-neurodegenerative-disorders
#26
REVIEW
Tiziana Bisogno, Vincenzo Di Marzo
The G-protein coupled receptors for Δ⁹-tetrahydrocannabinol, the major psychoactive principle of marijuana, are known as cannabinoid receptors of type 1 (CB₁) and 2 (CB₂) and play important functions in degenerative and inflammatory disorders of the central nervous system. Whilst CB₁ receptors are mostly expressed in neurons, where they regulate neurotransmitter release and synaptic strength, CB₂ receptors are found mostly in glial cells and microglia, which become activated and over-express these receptors during disorders such as Alzheimer's disease, multiple sclerosis, amyotropic lateral sclerosis, Parkinson's disease, and Huntington's chorea...
November 2010: CNS & Neurological Disorders Drug Targets
https://read.qxmd.com/read/20205673/protein-conformational-pathology-in-alzheimer-s-and-other-neurodegenerative-diseases-new-targets-for-therapy
#27
REVIEW
E Zerovnik
The whole set of so-called >conformational< disorders, among them systemic amyloidoses, various dementias and other neurodegenerative diseases such as Parkinson's, Alzheimer's and amyotropic lateral sclerosis, may have similar molecular backgrounds: changes in protein conformation and aggregation lead to toxic amyloid oligomers and fibrils. The so called aggresomes in eukaryotes (equivalent to inclusion bodies in prokaryotes), located at the centriole by the nucleus and composed of aggregated proteins, are believed to sequester the toxic material...
February 2010: Current Alzheimer Research
https://read.qxmd.com/read/19467572/minocycline-may-attenuate-postherpetic-neuralgia
#28
JOURNAL ARTICLE
Qiang Zhang, Liping Peng, Deren Zhang
Postherpetic neuralgia (PHN) is a chronic pain syndrome and one of the most common complications of herpes zoster. Although the pathophysiological mechanisms involved in PHN are still largely unknown, it seems reasonable to assume that there are lesions of the peripheral afferent pain pathways and inflammation-induced damage to afferent ganglia in the spinal cord. Growing body of evidence indicates that the glial cells, particularly microglia (CNS macrophages) and astrocytes are activated following peripheral and central noxious insult and their activation is thought to play an important role in central sensitization...
November 2009: Medical Hypotheses
https://read.qxmd.com/read/19455415/targeting-cdk5-activity-in-neuronal-degeneration-and-regeneration
#29
JOURNAL ARTICLE
Jyotshnabala Kanungo, Ya-li Zheng, Niranjana D Amin, Harish C Pant
The major priming event in neurodegeneration is loss of neurons. Loss of neurons by apoptotic mechanisms is a theme for studies focused on determining therapeutic strategies. Neurons following an insult, activate a number of signal transduction pathways, of which, kinases are the leading members. Cyclin-dependent kinase 5 (Cdk5) is one of the kinases that have been linked to neurodegeneration. Cdk5 along with its principal activator p35 is involved in multiple cellular functions ranging from neuronal differentiation and migration to synaptic transmission...
December 2009: Cellular and Molecular Neurobiology
https://read.qxmd.com/read/19436494/sod1-associated-als-a-promising-system-for-elucidating-the-origin-of-protein-misfolding-disease
#30
JOURNAL ARTICLE
Anna Nordlund, Mikael Oliveberg
Amyotropic lateral sclerosis (ALS) is a neurodegenerative disease linked to misfolding and aggregation of the homodimeric enzyme superoxide dismutase (SOD1). In contrast to the precursors of other neurodegenerative diseases, SOD1 is a soluble and simple-to-study protein with immunoglobulin-like structure. Also, there are more than 120 ALS-provoking SOD1 mutations at the disposal for detailed elucidation of the disease-triggering factors at molecular level. In this article, we review recent progress in the characterization of the folding and assembly pathway of the SOD1 dimer and how this is affected by ALS-provoking mutations...
December 2008: HFSP Journal
https://read.qxmd.com/read/19152750/a-decade-of-progress-since-the-birth-of-dolly
#31
REVIEW
Ian Wilmut, Gareth Sullivan, Jane Taylor
The greatest effect of the birth Dolly, the first cloned animal derived from an adult, has been in prompting biologists to consider ways of reprogramming adult nuclei to a pluripotent state directly. The first procedure depends upon use of viral vectors to introduce selected transcription factors, but this procedure is slow and very inefficient. Research in our laboratory has demonstrated that exposure of differentiated nuclei to an extract of embryo stem cells induces expression of key pluripotency genes within 8 h, suggesting that it may be possible to identify and use other factors to enhance direct reprogramming...
2009: Reproduction, Fertility, and Development
https://read.qxmd.com/read/18977395/minocycline-and-neurodegenerative-diseases
#32
REVIEW
Hye-Sun Kim, Yoo-Hun Suh
Minocycline is a semi-synthetic, second-generation tetracycline analog which is effectively crossing the blood-brain barrier, effective against gram-positive and -negative infections. In addition to its own antimicrobacterial properties, minocycline has been reported to exert neuroprotective effects over various experimental models such as cerebral ischemia, traumatic brain injury, amyotrophic lateral sclerosis, Parkinson's disease, kainic acid treatment, Huntington' disease and multiple sclerosis. Minocycline has been focused as a neuroprotective agent over neurodegenerative disease since it has been first reported that minocycline has neuroprotective effects in animal models of ischemic injury [Yrjanheikki J, Keinanen R, Pellikka M, Hokfelt T, Koisinaho J...
January 23, 2009: Behavioural Brain Research
https://read.qxmd.com/read/18781822/targeting-angiogenin-in-therapy-of-amyotropic-lateral-sclerosis
#33
REVIEW
Hiroko Kishikawa, David Wu, Guo-fu Hu
BACKGROUND: Missense heterozygous mutations in the coding region of angiogenin (ANG) gene, encoding a 14 kDa angiogenic RNase, were recently found in patients of amyotropic lateral sclerosis (ALS). Functional analyses have shown that these are loss-of-function mutations, implying that angiogenin deficiency is associated with ALS pathogenesis and that increasing ANG expression or angiogenin activity could be a novel approach for ALS therapy. OBJECTIVE: Review the evidence showing the involvement of angiogenin in motor neuron physiology and function, and provide a rationale for targeting angiogenin in ALS therapy...
October 2008: Expert Opinion on Therapeutic Targets
https://read.qxmd.com/read/18678378/influence-of-statins-treatment-on-survival-in-patients-with-amyotrophic-lateral-sclerosis
#34
JOURNAL ARTICLE
Vivian E Drory, Tatiana Bronipolsky, Irena Artamonov, Beatrice Nefussy
BACKGROUND: Statins are increasingly recognized as causing muscle damage and, more rarely, peripheral neuropathy. A preliminary report that there are more cases of amyotrophic lateral sclerosis (ALS) among people treated with statins caused considerable concern. We considered the possibility that statins could affect survival in patients already diagnosed as having amyotropic lateral sclerosis who were taking statins for dyslipidemia. METHODS: We reviewed the clinical charts of 459 patients with ALS followed-up in our clinic between 1997 and 2007...
October 15, 2008: Journal of the Neurological Sciences
https://read.qxmd.com/read/18627324/a-strategy-for-developing-effective-amyotropic-lateral-sclerosis-pharmacotherapy-from-clinical-trials-to-novel-pharmacotherapeutic-strategies
#35
REVIEW
Masahiko Yamamoto, Fumiaki Tanaka, Hiroshi Tatsumi, Gen Sobue
BACKGROUND: The pathomechanism of sporadic amyotropic lateral sclerosis is not clearly understood, although a proportion of familial amyotropic lateral sclerosis is caused by superoxide dismutase 1 mutations. Theories based on studies of human post-mortem tissue, research on animal models and in vitro work have been proposed for the pathogenesis of amyotropic lateral sclerosis, but the pathogenesis is not the same between sporadic and familial amyotropic lateral sclerosis. OBJECTIVE/METHODS: Drug candidates were tested using superoxide dismutase 1 mutant mice...
August 2008: Expert Opinion on Pharmacotherapy
https://read.qxmd.com/read/18509646/nox-enzymes-as-novel-targets-for-drug-development
#36
REVIEW
J David Lambeth, Karl-Heinz Krause, Robert A Clark
The members of the NOX/DUOX family of NADPH oxidases mediate such physiologic functions as host defense, cell signaling, and thyroid hormone biosynthesis through the generation of reactive oxygen species (ROS), including superoxide anion and hydrogen peroxide. Moreover, ROS are involved in a broad range of fundamental biochemical and cellular processes, and data accumulated in recent years indicate that the NOX enzymes comprise one of the most important biological sources of ROS. Given the high biochemical reactivity of ROS, it is not surprising that they have been implicated in a wide variety of pathologies and diseases...
July 2008: Seminars in Immunopathology
https://read.qxmd.com/read/18230051/histone-deacetylase-inhibitors-possible-implications-for-neurodegenerative-disorders
#37
REVIEW
Eric Hahnen, Jan Hauke, Christian Tränkle, Ilker Y Eyüpoglu, Brunhilde Wirth, Ingmar Blümcke
During the past six years numerous studies identified histone deacetylase (HDAC) inhibitors as candidate drugs for the treatment of neurodegenerative disorders. Two major neuroprotective mechanisms of HDAC inhibitors have been identified, namely the transcriptional activation of disease-modifying genes and the correction of perturbations in histone acetylation homeostasis, which have been shown to be intimately involved in the neurodegenerative pathomechanisms of Huntington's, Parkinson's and Kennedy disease, amyotropic lateral sclerosis, Rubinstein-Taybi syndrome as well as stroke...
February 2008: Expert Opinion on Investigational Drugs
https://read.qxmd.com/read/17604499/emerging-disease-modifying-therapies-for-the-treatment-of-motor-neuron-disease-amyotropic-lateral-sclerosis
#38
REVIEW
Richard S Bedlack, Bryan J Traynor, Merit E Cudkowicz
It has been > 130 years since the first description of the upper and lower motor neuron disease called amyotropic lateral sclerosis (ALS). Sadly, there has been little change in the long interval over which this disease is diagnosed, or in its poor prognosis. Significant gains have been made, however, in understanding its pathophysiology and in symptomatic care. Disease-causing mutations have been identified and used to create animal models. Other identified mutations may increase susceptibility and cause disease only in a particular environment and at a particular age...
May 2007: Expert Opinion on Emerging Drugs
https://read.qxmd.com/read/17531381/association-of-the-hogg1-ser326cys-polymorphism-with-sporadic-amyotrophic-lateral-sclerosis
#39
JOURNAL ARTICLE
Fabio Coppedè, Michelangelo Mancuso, Annalisa Lo Gerfo, Cecilia Carlesi, Selina Piazza, Anna Rocchi, Lucia Petrozzi, Claudia Nesti, Dario Micheli, Andrea Bacci, Lucia Migliore, Luigi Murri, Gabriele Siciliano
Amyotropic lateral sclerosis (ALS) is a fatal and progressive neurodegenerative disease causing the loss of motoneurons of the brain and the spinal cord. The etiology of ALS is still uncertain, but males are at increased risk for the disease than females. Several studies have suggested that motoneurons in ALS might be subjected to the double insult of increased DNA oxidative damage and deficiencies in DNA repair systems. Particularly, increased levels of 8-oxoguanine and impairments of the DNA base excision repair system have been observed in neurons of ALS patients...
June 13, 2007: Neuroscience Letters
https://read.qxmd.com/read/17397768/guidelines-on-the-use-of-intravenous-immune-globulin-for-neurologic-conditions
#40
JOURNAL ARTICLE
Tom Feasby, Brenda Banwell, Timothy Benstead, Vera Bril, Melissa Brouwers, Mark Freedman, Angelika Hahn, Heather Hume, John Freedman, David Pi, Louis Wadsworth
Canada's per capita use of intravenous immune globulin (IVIG) grew by approximately 115% between 1998 and 2006, making Canada one of the world's highest per capita users of IVIG. It is believed that most of this growth is attributable to off-label usage. To help ensure IVIG use is in keeping with an evidence-based approach to the practice of medicine, the National Advisory Committee on Blood and Blood Products (NAC) and Canadian Blood Services convened a panel of national experts to develop an evidence-based practice guideline on the use of IVIG for neurologic conditions...
April 2007: Transfusion Medicine Reviews
keyword
keyword
167255
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.